These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 28167400

  • 41. Subclinical atypical haemolytic uremic syndrome relapse following discontinuation of eculizumab.
    Choo SZ, Brown F.
    Nephrology (Carlton); 2017 Feb; 22 Suppl 1():4-6. PubMed ID: 28176471
    [Abstract] [Full Text] [Related]

  • 42. An effective treatment of atypical hemolytic uremic syndrome with plasma exchange and eculizumab: A case report.
    Sengul Samanci N, Ayer M, Ergen A, Ozturk S.
    Transfus Apher Sci; 2015 Jun; 52(3):314-6. PubMed ID: 25634788
    [Abstract] [Full Text] [Related]

  • 43. De novo systemic atypical hemolytic uremic syndrome in an ABO-incompatible living kidney transplant recipient with a novel pathogenic CFHR1 gene mutation successfully treated with eculizumab: a case report.
    Li D, Wang W, Chen R, Wen J, Zhang M.
    J Nephrol; 2022 Sep; 35(7):1895-1899. PubMed ID: 35852773
    [Abstract] [Full Text] [Related]

  • 44. Efficacy and safety of eculizumab in childhood atypical hemolytic uremic syndrome in Japan.
    Ito N, Hataya H, Saida K, Amano Y, Hidaka Y, Motoyoshi Y, Ohta T, Yoshida Y, Terano C, Iwasa T, Kubota W, Takada H, Hara T, Fujimura Y, Ito S.
    Clin Exp Nephrol; 2016 Apr; 20(2):265-72. PubMed ID: 26156042
    [Abstract] [Full Text] [Related]

  • 45. Postoperative Atypical Hemolytic Uremic Syndrome Treated Successfully with Eculizumab.
    Yasuda S, Yamamoto M, Fukuda T, Ohtsuka Y, Miura O.
    Intern Med; 2016 Apr; 55(9):1171-5. PubMed ID: 27150874
    [Abstract] [Full Text] [Related]

  • 46. Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome: requirement for comprehensive complement analysis.
    Wehling C, Kirschfink M.
    J Thromb Haemost; 2014 Sep; 12(9):1437-9. PubMed ID: 24942998
    [No Abstract] [Full Text] [Related]

  • 47. Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome: requirement for comprehensive complement analysis: comment.
    Cugno M, Tedeschi S, Ardissino G.
    J Thromb Haemost; 2015 Mar; 13(3):485-6. PubMed ID: 25345369
    [No Abstract] [Full Text] [Related]

  • 48. When to Stop Eculizumab in Complement-Mediated Thrombotic Microangiopathies.
    Olson SR, Lu E, Sulpizio E, Shatzel JJ, Rueda JF, DeLoughery TG.
    Am J Nephrol; 2018 Mar; 48(2):96-107. PubMed ID: 30110670
    [Abstract] [Full Text] [Related]

  • 49. Effective treatment of chemotherapy induced atypical Haemolytic Uraemic Syndrome: a case series of 7 treated patients.
    Weitz IC, Deloughery T.
    Br J Haematol; 2018 Oct; 183(1):136-139. PubMed ID: 28857126
    [No Abstract] [Full Text] [Related]

  • 50. An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome.
    Galbusera M, Noris M, Gastoldi S, Bresin E, Mele C, Breno M, Cuccarolo P, Alberti M, Valoti E, Piras R, Donadelli R, Vivarelli M, Murer L, Pecoraro C, Ferrari E, Perna A, Benigni A, Portalupi V, Remuzzi G.
    Am J Kidney Dis; 2019 Jul; 74(1):56-72. PubMed ID: 30851964
    [Abstract] [Full Text] [Related]

  • 51. [Recurrent atypical hemolytic uremic syndrome after renal transplantation: treatment with eculizumab].
    Latzke AB, Fernández P, Chiurchiu C, Sarmantano D, De Arteaga J, Douthat W, De la Fuente J.
    Medicina (B Aires); 2018 Jul; 78(2):119-122. PubMed ID: 29659362
    [Abstract] [Full Text] [Related]

  • 52. Atypical hemolytic uremic syndrome: a new drug program and first Polish adult patient treated with eculizumab.
    Ruszkowski J, Heleniak Z, Dębska-Ślizień A.
    Pol Merkur Lekarski; 2018 Sep 21; 45(267):119-121. PubMed ID: 30240381
    [Abstract] [Full Text] [Related]

  • 53. Glucose-6-Phosphate Dehydrogenase Deficiency Mimicking Atypical Hemolytic Uremic Syndrome.
    Walsh PR, Johnson S, Brocklebank V, Salvatore J, Christian M, Kavanagh D.
    Am J Kidney Dis; 2018 Feb 21; 71(2):287-290. PubMed ID: 29248304
    [Abstract] [Full Text] [Related]

  • 54. Atypical HUS due to factor H antibodies in an adult patient successfully treated with eculizumab.
    Green H, Harari E, Davidovits M, Blickstein D, Grossman A, Gafter U, Gafter-Gvili A.
    Ren Fail; 2014 Aug 21; 36(7):1119-21. PubMed ID: 24828571
    [Abstract] [Full Text] [Related]

  • 55. Liver transplantation for aHUS: still needed in the eculizumab era?
    Coppo R, Bonaudo R, Peruzzi RL, Amore A, Brunati A, Romagnoli R, Salizzoni M, Galbusera M, Gotti E, Daina E, Noris M, Remuzzi G.
    Pediatr Nephrol; 2016 May 21; 31(5):759-68. PubMed ID: 26604087
    [Abstract] [Full Text] [Related]

  • 56. A case of renal recovery in atypical hemolytic uremic syndrome treated with eculizumab.
    Farias JS, Cunha JP, Lagana CC, Gallucci MC, Chula DC, Soares MF, Nascimento MM.
    J Bras Nefrol; 2016 Mar 21; 38(1):137-41. PubMed ID: 27049376
    [Abstract] [Full Text] [Related]

  • 57. Novel biomarker and easy to perform ELISA for monitoring complement inhibition in patients with atypical hemolytic uremic syndrome treated with eculizumab.
    Riedl M, Hofer J, Giner T, Rosales A, Häffner K, Simonetti GD, Walden U, Maier T, Heininger D, Jeller V, Weiss G, van den Heuvel L, Zimmerhackl LB, Würzner R, Jungraithmayr TC.
    J Immunol Methods; 2016 Aug 21; 435():60-7. PubMed ID: 27238216
    [Abstract] [Full Text] [Related]

  • 58. Is eculizumab indicated in patients with atypical hemolytic uremic syndrome already on prolonged dialysis? A case report and review of the literature.
    Haskin O, Falush Y, Davidovits M.
    Pediatr Nephrol; 2019 Dec 21; 34(12):2601-2604. PubMed ID: 31520126
    [Abstract] [Full Text] [Related]

  • 59. [Atypical hemolytic uremic syndrome (aHUS): new insights into pathogenesis leading to novel therapeutic approaches].
    Kistler AD.
    Praxis (Bern 1994); 2016 Mar 30; 105(7):389-96. PubMed ID: 27005733
    [Abstract] [Full Text] [Related]

  • 60. Life-threatening pregnancy-associated atypical haemolytic uraemic syndrome and its response to eculizumab.
    Gately R, San A, Kurtkoti J, Parnham A.
    Nephrology (Carlton); 2017 Feb 30; 22 Suppl 1():32-35. PubMed ID: 28176475
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.